Navigation Links
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Date:1/26/2009

key contributors to why physicians have quickly adopted XIENCE V, making it the market-leading drug eluting stent in the United States and in key markets around the world."

About the SPIRIT III Trial

SPIRIT III is a prospective, multi-center, randomized, single-blind, controlled clinical trial comparing XIENCE V to TAXUS in 1,002 patients (669 XIENCE V patients, 333 TAXUS patients) with either one or two de novo native coronary artery lesions. The trial was conducted across 65 academic and community-based centers in the United States between June 22, 2005, and March 15, 2006.

The primary endpoint of the SPIRIT III trial was in-segment late loss at eight months, wherein XIENCE V demonstrated superiority to TAXUS with a statistically significant 50 percent reduction in late loss (mean, 0.14 mm for XIENCE V vs. 0.28 mm for TAXUS). In-segment late loss is a measure of vessel renarrowing. In the co-primary endpoint of TVF at nine months, XIENCE V demonstrated statistical non-inferiority compared to TAXUS with an observed 20 percent reduction in TVF (7.2 percent for XIENCE V vs. 9.0 percent for TAXUS).

Additionally, in the pre-specified secondary endpoint of MACE, XIENCE V demonstrated a 43 percent reduction at nine months (4.6 percent for XIENCE V vs. 8.1 percent for TAXUS) and a 42 percent reduction in MACE at one year (6.0 percent for XIENCE V vs. 10.3 percent for TAXUS) compared to TAXUS.

About XIENCE V

XIENCE V is used to treat coronary artery disease by propping open a narrowed or blocked artery and releasing the drug, everolimus, in a controlled manner to prevent the artery from becoming blocked again following a stent procedure. XIENCE V is built upon Abbott's market-leading bare metal stent, the MULTI-LINK VISION(R) Coronary Stent System. The VISION platform is designed to facilitate ease of delivery, making it easier for physicians to maneuver the
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
2. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
7. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
8. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
9. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
10. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
11. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... BEDFORD, Massachusetts , 17 settembre 2014 /PRNewswire/ ... ha annunciato oggi il lancio in Europa del ... Il Tomcat è una piattaforma multifunzionale completamente automatizzata, ... tutte le inefficienze ed i rischi di errore ... "L,elevata automazione dello strumento Tomcat di Hologic riduce ...
(Date:9/16/2014)... 2014 3SBio Inc., ("3SBio") a leading ... focusing on researching, developing, manufacturing and marketing ... into an exclusive license agreement with JenKem Technology ... marketing in Mainland China of PEG-irinotecan, a long-acting ... is over-expressed in many solid tumors, including colorectal, ...
(Date:9/16/2014)... Ill. , Sept. 16, 2014 ... new director of Business Communications & Advocacy, Urology ... President, Business Communications & Advocacy Margaret Long. In this ... commitment to urology to patient and advocacy organizations, ... teams on key strategic initiatives. Noland,s appointment is ...
Breaking Medicine Technology:Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 2Hologic annuncia il lancio dello strumento preanalitico Tomcat in Europa 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5Christy Noland to Lead Urology Advocacy and Communications for Astellas 2
(Date:9/17/2014)... (PRWEB) September 17, 2014 Angeldress.co.uk ... kinds of graceful special occasion outfits for worldwide clients. ... officials are thinking of opening the first flagship retail ... fashion industry. Recently, the company has unveiled its new ... promotion. , All its new products are offered ...
(Date:9/17/2014)... In a new video released for ... expert on the condition known as PPP, demonstrates a proven ... or PPP, is a condition that affects mostly uncircumcised men ... affected as well. The condition is characterized by small bumps ... is not a sexually transmitted disease and generally has no ...
(Date:9/17/2014)... Holon Solutions announced today that ... CollaborNet™ Health Information Exchange (HIE) solution ... between Coon Memorial Hospital, a 21-bed critical access ... community. , Coon Memorial is also using ... by physicians to the state’s Quitline tobacco cessation ...
(Date:9/17/2014)... Detroit, MI (PRWEB) September 17, 2014 ... are excited to be of the first in ... Ultherapy Décolletage Treatment, specifically designed to minimize the appearance ... Ultherapy, made waves in 2012 with the first FDA-cleared ... and face, and now they have expanded their brand ...
(Date:9/17/2014)... September 17, 2014 Lee Berman, a ... will be appearing on The Balancing Act® airing on ... episodes. , The segment will premiere on September 19 ... Balancing Act® airing on Lifetime Television®' with show host ... Funding Corp. for over a decade and is the ...
Breaking Medicine News(10 mins):Health News:Angeldress.co.uk Is Planning To Open Its First Retail Store And Offering Big Savings On Amazing Wedding Dresses 2Health News:New Video Depicts Best Treatment for PPP 2Health News:New Video Depicts Best Treatment for PPP 3Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 2Health News:Dallam-Hartley Counties Hospital District Deploys Holon's Health Information Exchange (HIE) Solution to Facilitate Improved Patient Care 3Health News:FACE Skincare Medical Wellness Debuts Ultherapy Décolletage Treatment 2Health News:Lee Berman Will Appear On The Balancing Act® airing on Lifetime Television® 2
... cancer, found in dogs, wolves and coyotes, can repair its ... according to a new study in the journal Science ... unusual process that helps the cancer survive by stealing tiny ... infected animal, to incorporate as its own. They say this ...
... Amanda Gardner HealthDay Reporter , THURSDAY, Jan. 20 ... very differently depending on what side of the Atlantic ... ("swine") flu still predominated in Britain, where 112 people have ... and some doctors report running out of vaccine, according to ...
... The American Institute of Ultrasound in Medicine (AIUM) announced ... Fetal Echocardiography. The program sets the standard for care ... AIUM guidelines aimed at fostering its safe and effective ... a way for healthcare providers to show that they ...
... notion that feeling good may be good for your health ... article published in Current Directions in Psychological Science , ... existing research on how positive emotions can influence health outcomes ... how we age, however, that determines the quality of our ...
... Journal on Addictions reveals that illicit use of ... American male weightlifters. Additionally, illicit HGH use in this ... performance-enhancing and classical drugs. HGH, once an expensive ... cheaply available for illicit users on the street. ...
... , WEDNESDAY, Jan. 19 (HealthDay News) -- Scientists studying ... critters become resistant to pesticides, and the finding could ... across the United States. "We are starting to ... researcher Omprakash Mittapalli, an assistant professor of entomology at ...
Cached Medicine News:Health News:Contagious cancer thrives in dogs by adopting host's genes 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 2Health News:H1N1 Flu Is Raging in Britain; Could U.S. Be Next? 3Health News:AIUM announces ultrasound practice accreditation in fetal echocardiography 2Health News:Bedbugs Reveal Their Genetic Secrets in Lab Study 2Health News:Bedbugs Reveal Their Genetic Secrets in Lab Study 3
Tennant straight tying forceps with extra delicate smooth jaws, 6 mm tying platform, For 9-0 to 11-0 sutures. Overall length 108 mm....
Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
McPherson curved tying forceps is long has curved shafts with tying platform 4 mm, serrated handle and polished finish. Overall length 110 mm....
McPherson straight tying forceps have straight shafts, tying platforms 4 mm, serrated handle, polished finish, overall length 85 mm....
Medicine Products: